Issue 19, 2017

Luminescent iridium(iii) complexes as COX-2-specific imaging agents in cancer cells

Abstract

Two luminescent iridium(III) complexes, 1 and 2, were synthesized and evaluated for their ability to probe COX-2 in human cancer cells. This is the first application of iridium(III) complexes as imaging agents for COX-2. We demonstrate that complex 1 differentiates cancer cells from normal cells with high stability and low cytotoxicity.

Graphical abstract: Luminescent iridium(iii) complexes as COX-2-specific imaging agents in cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
07 Oct 2016
Accepted
16 Jan 2017
First published
16 Jan 2017

Chem. Commun., 2017,53, 2822-2825

Luminescent iridium(III) complexes as COX-2-specific imaging agents in cancer cells

C. Liu, C. Yang, L. Lu, W. Wang, W. Tan, C. Leung and D. Ma, Chem. Commun., 2017, 53, 2822 DOI: 10.1039/C6CC08109F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements